A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis Dependent
Phase of Trial: Phase I/II
Latest Information Update: 16 Oct 2019
Price : $35 *
At a glance
- Drugs Daprodustat (Primary) ; Acetylcholine; Darbepoetin alfa; Sodium nitroprusside
- Indications Anaemia
- Focus Pharmacodynamics
- Acronyms FBF-CKD
- Sponsors GlaxoSmithKline
- 12 May 2019 Planned number of patients changed from 50 to 62.
- 04 Feb 2019 Status changed from not yet recruiting to recruiting.
- 08 Jan 2019 Planned End Date changed from 2 Dec 2019 to 21 Jan 2020.